Comparison of treatment outcomes between intermittent and daily regimens in non-cavitary nodular bronchiectatic-type <i>Mycobacterium avium</i> complex pulmonary disease in relation to sputum smear results: a retrospective cohort study
Junghee Jung, Yong Pil Chong, Hyun Joo Lee, Tae Sun Shim, Kyung‐Wook Jo
Antimicrobial Agents and Chemotherapy · 2023-10
Abstract
ABSTRACT This study retrospectively analyzed the treatment outcomes of 110 patients with non-cavitary nodular bronchiectatic-type Mycobacterium avium complex pulmonary disease who received intermittent or daily treatment with a three-drug oral antibiotic regimen (i.e., a macrolide, ethambutol, and rifampin) at a tertiary referral center in South Korea. Among these patients, 36 had sputum smear positivity. Of these 36 patients, intermittent treatment led to a lower culture conversion rate than daily treatment [50.0% (8/16) vs 85.0% (17/20), P = 0.034].
MeSH terms
- Medicine
- Ethambutol
- Culture conversion
- Sputum
- Bronchiectasis
- Internal medicine
- Retrospective cohort study
- Sputum culture
- Mycobacterium avium complex
- Regimen
- Antibiotics
- Surgery
- Gastroenterology